Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas
暂无分享,去创建一个
A. Concha | F. Garrido | T. Cabrera | J. Cózar | M. Tallada | J. Cantón | Francisco Ruiz-Cabello Osuna
[1] S. Horita,et al. High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma. , 2004, The Journal of urology.
[2] B. Seliger,et al. Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas , 2004, International journal of cancer.
[3] Marlene Wolf,et al. Chemokines: multiple levels of leukocyte migration control. , 2004, Trends in immunology.
[4] Shimon Sakaguchi,et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. , 2004, International immunology.
[5] L. Khawli,et al. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion. , 2003, Cancer research.
[6] D. Pardoll,et al. Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.
[7] P. Kuppen,et al. NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. , 2003, Trends in immunology.
[8] C. Falk,et al. Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes , 2003, International journal of cancer.
[9] P. Morel,et al. Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function 1 , 2003, The Journal of Immunology.
[10] F. Garrido,et al. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. , 2003, Tissue antigens.
[11] Michal Schwartz,et al. Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk'. , 2002, Trends in immunology.
[12] F. Garrido,et al. Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy. , 2002, Seminars in cancer biology.
[13] B. Longenecker,et al. MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment , 2001, Glycoconjugate Journal.
[14] S. Natsugoe,et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma , 2000, Cancer.
[15] P. Klenerman,et al. Immune surveillance against a solid tumor fails because of immunological ignorance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] C. Mackay,et al. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.
[17] P. Allavena,et al. Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.
[18] P. Stern,et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. , 1997, Immunology today.
[19] D. Longo,et al. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. , 1992, Science.
[20] J. Roth. Tumor induced immunosuppression. , 1983, Surgery, gynecology & obstetrics.
[21] E. Shevach,et al. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. , 2004, Immunity.
[22] S. Coca,et al. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. , 2002, Lung cancer.
[23] E. Régulier,et al. [Tumor-induced immunosuppression]. , 2002, Annales de biologie clinique.
[24] F. Marincola,et al. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.